한글목차

과민성대장증후군 시장(2024-2028년)

과민성대장증후군 시장은 2023-2028년에 19억 3,190만 달러에 달하며, 예측 기간 중 CAGR은 9.3%로 성장할 것으로 예측됩니다. 과민성대장증후군 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.

현재 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 시장은 IBS의 유병률 증가, IBS에 대한 인식과 진단의 증가, 세계 헬스케어 지출의 증가가 촉진하고 있습니다.

본 조사에서는 향후 수년간 과민성대장증후군 시장 성장을 촉진하는 주요 요인의 하나로 의약품 승인 건수의 증가를 들고 있습니다. 또한 벤더간 제휴 및 공동 연구, IBS 치료제로서 amitriptyline의 탐구는 시장의 큰 수요로 연결됩니다.

목차

제1장 개요

• 시장 개요

제2장 Technavio 분석

• 가격 민감도·수명주기·고객 구입 바스켓·채택률·구입 기준 분석
• 인풋의 중요성과 차별화의 요인
• 혼란의 요인
• 촉진요인과 과제의 영향

제3장 시장 구도

• 시장 에코시스템
• 시장의 특징
• 밸류체인 분석

제4장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모, 2023년
• 시장 전망, 2023-2028년

제5장 시장 규모 실적

• 세계의 과민성대장증후군 시장, 2018-2022년
• 유형 부문 분석, 2018-2022년
• 약제 클래스 부문 분석, 2018-2022년
• 지역별 부문 분석, 2018-2022년
• 국가별 부문 분석, 2018-2022년

제6장 정성 분석

• 세계 과민성대장증후군 시장에서 AI의 영향

제7장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 현황

제8장 시장 세분화 : 유형별

• 시장 부문
• 비교 : 유형별
• IBS-D : 시장 규모와 예측, 2023-2028년
• IBS-C : 시장 규모와 예측, 2023-2028년
• IBS-M : 시장 규모와 예측, 2023-2028년
• 시장 기회 : 유형별

제9장 시장 세분화 : 약제 클래스별

• 시장 부문
• 비교 : 약제 클래스별
• 항생제 : 시장 규모와 예측, 2023-2028년
• Guanylate cyclase-C 작용제 : 시장 규모와 예측, 2023-2028년
• μ오피오이드 수용체 작용제 : 시장 규모와 예측, 2023-2028년
• 염소 이온채널 활성화제 : 시장 규모와 예측, 2023-2028년
• 기타 : 시장 규모와 예측, 2023-2028년
• 시장 기회 : 약제 클래스별

제10장 고객 상황

• 고객 상황의 개요

제11장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측, 2023-2028년
• 유럽 : 시장 규모와 예측, 2023-2028년
• 아시아 : 시장 규모와 예측, 2023-2028년
• 세계의 기타 지역 : 시장 규모와 예측, 2023-2028년
• 미국 : 시장 규모와 예측, 2023-2028년
• 중국 : 시장 규모와 예측, 2023-2028년
• 독일 : 시장 규모와 예측, 2023-2028년
• 일본 : 시장 규모와 예측, 2023-2028년
• 영국 : 시장 규모와 예측, 2023-2028년
• 인도 : 시장 규모와 예측, 2023-2028년
• 프랑스 : 시장 규모와 예측, 2023-2028년
• 캐나다 : 시장 규모와 예측, 2023-2028년
• 호주 : 시장 규모와 예측, 2023-2028년
• 브라질 : 시장 규모와 예측, 2023-2028년
• 시장 기회 : 지역 상황별

제12장 촉진요인·과제·기회·억제요인

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 촉진요인과 과제의 영향
• 시장의 기회·억제요인

제13장 경쟁 구도

• 개요
• 경쟁 구도
• 혼란 상황
• 업계 리스크

제14장 경쟁 분석

• 기업 개요
• 기업 순위 지수
• 기업의 시장 포지셔닝
• AbbVie Inc.
• Alfasigma Spa
• Astellas Pharma Inc.
• AstraZeneca Plc
• Bausch Health Companies Inc.
• Bayer AG
• Boehringer Ingelheim International GmbH
• Ironwood Pharmaceuticals Inc
• Mallinckrodt Plc
• Nestle Health Science S.A.
• Novartis AG
• Pfizer Inc.
• Sanofi SA
• Sebela Pharmaceuticals Inc.
• Takeda Pharmaceutical Co. Ltd.

제15장 부록

영문목차

Irritable Bowel Syndrome Market 2024-2028

The irritable bowel syndrome market is forecasted to grow by USD 1931.9 mn during 2023-2028, accelerating at a CAGR of 9.3% during the forecast period. The report on the irritable bowel syndrome market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of ibs, growing awareness and diagnosis of ibs, and rising global healthcare expenditure.

Technavio's irritable bowel syndrome market is segmented as below:

By Type

• IBS-D
• IBS-C
• IBS-M

By Drug Class

• Antibiotics
• Guanylate cyclase-C agonists
• Mu-opioid receptor agonists
• Chloride channel activators
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing number of drug approvals as one of the prime reasons driving the irritable bowel syndrome market growth during the next few years. Also, partnerships and collaborations among vendors and exploration of amitriptyline as treatment for ibs will lead to sizable demand in the market.

The report on the irritable bowel syndrome market covers the following areas:

• Irritable Bowel Syndrome Market sizing
• Irritable Bowel Syndrome Market forecast
• Irritable Bowel Syndrome Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading irritable bowel syndrome market vendors that include Abbott Laboratories, AbbVie Inc., Alfasigma Spa, Astellas Pharma Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bayer AG, Boehringer Ingelheim International GmbH, GlaxoSmithKline Plc, Ironwood Pharmaceuticals Inc, Johnson and Johnson Services Inc., Mallinckrodt Plc, Nestle Health Science S.A., Novartis AG, Pfizer Inc., RedHill Biopharma Ltd., Sanofi SA, Sebela Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the irritable bowel syndrome market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Drug Class
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value Chain Analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2023
• 4.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

• 5.1 Global Irritable Bowel Syndrome Market 2018 - 2022
  • Historic Market Size - Data Table on Global Irritable Bowel Syndrome Market 2018 - 2022 ($ million)
• 5.2 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 5.3 Drug Class segment analysis 2018 - 2022
  • Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
• 5.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 5.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on the Global Irritable Bowel Syndrome Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 7.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Type

• 8.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
• 8.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 8.3 IBS-D - Market size and forecast 2023-2028
  • Chart on IBS-D - Market size and forecast 2023-2028 ($ million)
  • Data Table on IBS-D - Market size and forecast 2023-2028 ($ million)
  • Chart on IBS-D - Year-over-year growth 2023-2028 (%)
  • Data Table on IBS-D - Year-over-year growth 2023-2028 (%)
• 8.4 IBS-C - Market size and forecast 2023-2028
  • Chart on IBS-C - Market size and forecast 2023-2028 ($ million)
  • Data Table on IBS-C - Market size and forecast 2023-2028 ($ million)
  • Chart on IBS-C - Year-over-year growth 2023-2028 (%)
  • Data Table on IBS-C - Year-over-year growth 2023-2028 (%)
• 8.5 IBS-M - Market size and forecast 2023-2028
  • Chart on IBS-M - Market size and forecast 2023-2028 ($ million)
  • Data Table on IBS-M - Market size and forecast 2023-2028 ($ million)
  • Chart on IBS-M - Year-over-year growth 2023-2028 (%)
  • Data Table on IBS-M - Year-over-year growth 2023-2028 (%)
• 8.6 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by Drug Class

• 9.1 Market segments
  • Chart on Drug Class - Market share 2023-2028 (%)
  • Data Table on Drug Class - Market share 2023-2028 (%)
• 9.2 Comparison by Drug Class
  • Chart on Comparison by Drug Class
  • Data Table on Comparison by Drug Class
• 9.3 Antibiotics - Market size and forecast 2023-2028
  • Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
  • Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
  • Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
  • Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
• 9.4 Guanylate cyclase-C agonists - Market size and forecast 2023-2028
  • Chart on Guanylate cyclase-C agonists - Market size and forecast 2023-2028 ($ million)
  • Data Table on Guanylate cyclase-C agonists - Market size and forecast 2023-2028 ($ million)
  • Chart on Guanylate cyclase-C agonists - Year-over-year growth 2023-2028 (%)
  • Data Table on Guanylate cyclase-C agonists - Year-over-year growth 2023-2028 (%)
• 9.5 Mu-opioid receptor agonists - Market size and forecast 2023-2028
  • Chart on Mu-opioid receptor agonists - Market size and forecast 2023-2028 ($ million)
  • Data Table on Mu-opioid receptor agonists - Market size and forecast 2023-2028 ($ million)
  • Chart on Mu-opioid receptor agonists - Year-over-year growth 2023-2028 (%)
  • Data Table on Mu-opioid receptor agonists - Year-over-year growth 2023-2028 (%)
• 9.6 Chloride channel activators - Market size and forecast 2023-2028
  • Chart on Chloride channel activators - Market size and forecast 2023-2028 ($ million)
  • Data Table on Chloride channel activators - Market size and forecast 2023-2028 ($ million)
  • Chart on Chloride channel activators - Year-over-year growth 2023-2028 (%)
  • Data Table on Chloride channel activators - Year-over-year growth 2023-2028 (%)
• 9.7 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
• 9.8 Market opportunity by Drug Class
  • Market opportunity by Drug Class ($ million)
  • Data Table on Market opportunity by Drug Class ($ million)

10 Customer Landscape

• 10.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

• 11.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 11.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 11.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 11.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 11.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 11.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 11.8 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 11.9 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 11.10 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 11.11 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 11.12 India - Market size and forecast 2023-2028
  • Chart on India - Market size and forecast 2023-2028 ($ million)
  • Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Chart on India - Year-over-year growth 2023-2028 (%)
  • Data Table on India - Year-over-year growth 2023-2028 (%)
• 11.13 France - Market size and forecast 2023-2028
  • Chart on France - Market size and forecast 2023-2028 ($ million)
  • Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Chart on France - Year-over-year growth 2023-2028 (%)
  • Data Table on France - Year-over-year growth 2023-2028 (%)
• 11.14 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 11.15 Australia - Market size and forecast 2023-2028
  • Chart on Australia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Australia - Market size and forecast 2023-2028 ($ million)
  • Chart on Australia - Year-over-year growth 2023-2028 (%)
  • Data Table on Australia - Year-over-year growth 2023-2028 (%)
• 11.16 Brazil - Market size and forecast 2023-2028
  • Chart on Brazil - Market size and forecast 2023-2028 ($ million)
  • Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
  • Chart on Brazil - Year-over-year growth 2023-2028 (%)
  • Data Table on Brazil - Year-over-year growth 2023-2028 (%)
• 11.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

• 12.1 Market drivers
• 12.2 Market challenges
• 12.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 12.4 Market opportunities/restraints

13 Competitive Landscape

• 13.1 Overview
• 13.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 13.3 Landscape disruption
  • Overview on factors of disruption
• 13.4 Industry risks
  • Impact of key risks on business

14 Competitive Analysis

• 14.1 Companies profiled
  • Companies covered
• 14.2 Company ranking index
  • Company ranking index
• 14.3 Market positioning of companies
  • Matrix on companies position and classification
• 14.4 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
  • SWOT
• 14.5 Alfasigma Spa
  • Alfasigma Spa - Overview
  • Alfasigma Spa - Product / Service
  • Alfasigma Spa - Key offerings
  • SWOT
• 14.6 Astellas Pharma Inc.
  • Astellas Pharma Inc. - Overview
  • Astellas Pharma Inc. - Product / Service
  • Astellas Pharma Inc. - Key offerings
  • SWOT
• 14.7 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
  • SWOT
• 14.8 Bausch Health Companies Inc.
  • Bausch Health Companies Inc. - Overview
  • Bausch Health Companies Inc. - Business segments
  • Bausch Health Companies Inc. - Key news
  • Bausch Health Companies Inc. - Key offerings
  • Bausch Health Companies Inc. - Segment focus
  • SWOT
• 14.9 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key news
  • Bayer AG - Key offerings
  • Bayer AG - Segment focus
  • SWOT
• 14.10 Boehringer Ingelheim International GmbH
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Product / Service
  • Boehringer Ingelheim International GmbH - Key news
  • Boehringer Ingelheim International GmbH - Key offerings
  • SWOT
• 14.11 Ironwood Pharmaceuticals Inc
  • Ironwood Pharmaceuticals Inc - Overview
  • Ironwood Pharmaceuticals Inc - Product / Service
  • Ironwood Pharmaceuticals Inc - Key offerings
  • SWOT
• 14.12 Mallinckrodt Plc
  • Mallinckrodt Plc - Overview
  • Mallinckrodt Plc - Business segments
  • Mallinckrodt Plc - Key news
  • Mallinckrodt Plc - Key offerings
  • Mallinckrodt Plc - Segment focus
  • SWOT
• 14.13 Nestle Health Science S.A.
  • Nestle Health Science S.A. - Overview
  • Nestle Health Science S.A. - Product / Service
  • Nestle Health Science S.A. - Key offerings
  • SWOT
• 14.14 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
  • SWOT
• 14.15 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
• 14.16 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
  • SWOT
• 14.17 Sebela Pharmaceuticals Inc.
  • Sebela Pharmaceuticals Inc. - Overview
  • Sebela Pharmaceuticals Inc. - Product / Service
  • Sebela Pharmaceuticals Inc. - Key offerings
  • SWOT
• 14.18 Takeda Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Takeda Pharmaceutical Co. Ltd. - Key news
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
  • SWOT

15 Appendix

• 15.1 Scope of the report
• 15.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 15.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 15.4 Research methodology
  • Research methodology
• 15.5 Data procurement
  • Information sources
• 15.6 Data validation
  • Data validation
• 15.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 15.8 Data synthesis
  • Data synthesis
• 15.9 360 degree market analysis
  • 360 degree market analysis
• 15.10 List of abbreviations
  • List of abbreviations